This NDC is on FDA's drug shortage list (posted Dec 22, 2021)

Product Information

RIFAMPIN 300 MG CAPSULE is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.6791 per EA under NDC 68180065907. Its NADAC has been published 670 times since Jan 22, 2014.

FDA first approved this application on Aug 21, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RIFAMPIN 300 MG CAPSULE

rifampin
$0.6791per EA

Strength

300 mg/1

NDC

68180065907

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

RIFAMPIN

Approval Type

Generic (ANDA)

FDA Application

ANDA090034

FDA Approved

8/21/2013

TE Code

AB

On Market Since

1/8/2014

Pharmacological Classes

Price Statistics

The NADAC for RIFAMPIN 300 MG CAPSULE has been published 670 times since Jan 22, 2014, and over the history we have for it it has declined 36.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6791 per EA
All-time high$1.2801 (Aug 13, 2014)
All-time low$0.4888 (Nov 20, 2024)
52-week high$0.7021
52-week low$0.6717
Median price$0.7078
Average price$0.7544
Largest weekly change-29.8% (Apr 20, 2022)
Weeks tracked670
Tracking sinceJan 22, 2014

Price History

1W

+1.1%

1M

+0.0%

3M

-0.2%

6M

-1.9%

1Y

-3.3%

3Y

+3.4%

5Y

+4.0%

All

-36.0%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of RIFAMPIN 300 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for RIFAMPIN 300 MG CAPSULE, manufactured by Lupin Pharmaceuticals Inc., is $0.6791 per EA (NDC 68180065907), effective Nov 18, 2026.

How has the price of RIFAMPIN 300 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for RIFAMPIN 300 MG CAPSULE has declined 36.0%. It has been tracked across 670 weekly CMS publications since Jan 22, 2014.

What are the highest and lowest recorded NADAC prices for RIFAMPIN 300 MG CAPSULE?

Since Jan 22, 2014, the NADAC for RIFAMPIN 300 MG CAPSULE has ranged from a low of $0.4888 (Nov 20, 2024) to a high of $1.2801 (Aug 13, 2014), with a median of $0.7078 per EA.

Are there cheaper alternatives to RIFAMPIN 300 MG CAPSULE?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RIFAMPIN 300 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures RIFAMPIN 300 MG CAPSULE?

RIFAMPIN 300 MG CAPSULE (NDC 68180065907) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.

Is RIFAMPIN 300 MG CAPSULE in shortage?

Yes — NDC 68180065907 is currently listed in FDA's drug shortage database (posted Dec 22, 2021).